CSPC Pharmaceutical Group Limited
CSPCY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $88 | $54 | $72 | $85 |
| - Cash | $8 | $7 | $8 | $12 |
| + Debt | $0 | $1 | $0 | $1 |
| Enterprise Value | $81 | $48 | $64 | $74 |
| Revenue | $2 | $15 | $16 | $8 |
| % Growth | -87.5% | -10.4% | 114.6% | – |
| Gross Profit | $1 | $10 | $12 | $19 |
| % Margin | 65.6% | 68.2% | 71.6% | 246.3% |
| EBITDA | $3 | $2 | $5 | $2 |
| % Margin | 190.2% | 17.1% | 27.8% | 23.6% |
| Net Income | $0 | $2 | $3 | $1 |
| % Margin | 19.2% | 10.9% | 18.5% | 18.2% |
| EPS Diluted | 0.12 | 0.48 | 1.08 | 1.44 |
| % Growth | -75% | -55.6% | -25% | – |
| Operating Cash Flow | $0 | $3 | $1 | $3 |
| Capital Expenditures | -$0 | $1 | -$1 | -$1 |
| Free Cash Flow | $0 | -$1 | $1 | $2 |